Sigilon Therapeutics (SGTX) PT Raised to $21 at Morgan Stanley
Tweet
Share
E-mailGet Alerts SGTX Hot Sheet
Price: $22.47 --0%
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 8
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 8
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Sigilon Therapeutics (NASDAQ: SGTX) to $21.00 (from $7.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Bullish (BLSH) PT Raised to $30 at Compass Point
- Cellebrite (CLBT) PT Lowered to $12.50 at Needham
- Nuscale Power (SMR) PT Lowered to $15 at B.Riley
Create E-mail Alert Related Categories
Analyst PT Change, Hot CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
